syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516073
SECKEL SYNDROME 10; SCKL10	1.25	46.89518779215467
MYOCLONIC-ASTASTIC EPILEPSY	1.22839834	46.084776670296854
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.782803437094614
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687592
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	38.16390483398221
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	38.16298118636347
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.014250339	38.050768092529225
PAROXYSMAL KINESIGENIC DYSKINESIA	1.00980392	37.88395556932315
SENGERS SYNDROME	1.00684932	37.77311035184258
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.00537634	37.717849812871314
LOWRY-MACLEAN SYNDROME	1.000541419	37.53646219026713
SPLENOPORTAL VASCULAR ANOMALIES	1.0	37.516150233723735
CHIARI MALFORMATION TYPE II	1.0	37.516150233723735
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	37.516150233723735
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0	37.516150233723735
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	35.01506104609208
LAFORA DISEASE	0.7769052999999999	29.146495952176206
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706170999999999	28.91058689627651
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.74803341	28.063333789404666
EARLY MYOCLONIC ENCEPHALOPATHY	0.7178920999999999	26.932547875203422
GITELMAN SYNDROME	0.70638644	26.500899806105277
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6794116299999999	25.488908781619124
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.6510022200000001	24.423097088007676
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.645995919	24.23527994757643
GLUTARIC ACIDEMIA I; GA1	0.628735789	23.58774631744283
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.6118624890000001	22.95472505970414
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6103603	22.898368711500687
PAROXYSMAL HEMICRANIA	0.6098039199999999	22.877495475833648
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.6055556	22.718114864472717
ROLANDIC EPILEPSY	0.6004252200000001	22.52564275763663
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.5999174890000001	22.506594645162313
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309237
HSD10 DISEASE	0.583874419	21.904720420832163
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.535437929	20.087569785197903
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.008600952602585
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.52601025	19.73387956347858
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.52412562	19.663175501263595
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.52092826	19.5432228631523
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50980392	19.125880452461274
GLYCINE ENCEPHALOPATHY	0.50925926	19.105446906074977
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.50925926	19.105446906074977
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.50392157	18.905197326133933
INHALATIONAL ANTHRAX	0.50373134	18.898060628874973
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5	18.758075116861868
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.5	18.758075116861868
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.5	18.758075116861868
RENAL TUBULAR ACIDOSIS III	0.5	18.758075116861868
BARTH SYNDROME; BTHS	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
CREST SYNDROME	0.5	18.758075116861868
TRIGEMINAL NEURALGIA	0.5	18.758075116861868
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5	18.758075116861868
CLUSTER HEADACHE, FAMILIAL	0.5	18.758075116861868
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	17.962263780029005
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.457390739	17.159539679837923
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.45148625	16.93802598346055
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064626
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41458575	15.55366128176103
SPINOCEREBELLAR ATAXIA TYPE 10	0.40889129999999996	15.3400274400626
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.570140138202744
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.37769548999999997	14.1696807454399
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.3655911	13.715570631712318
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.35559819	13.340675118880238
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
ACUTE ADRENAL INSUFFICIENCY	0.35423968899999997	13.289709391271574
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3505744	13.152201858497559
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.35054141899999997	13.150964538346699
INSULINOMA	0.34974801899999997	13.121199224751262
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.34717764999999995	13.024768875191157
HYDROXYKYNURENINURIA	0.3437497	12.896165387997463
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34371794999999994	12.894974250227541
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070942
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.34054108899999996	12.775790655679883
ADDISON DISEASE	0.34054108899999996	12.775790655679883
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.34018232	12.762331023976683
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.338945789	12.715941141212026
COG4-CDG	0.33725457	12.652493115129898
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333874419	12.525682862401228
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.333874419	12.525682862401228
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333874419	12.525682862401228
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	12.505370905857834
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	12.505370905857834
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.32922692000000003	12.351326591706147
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.3215277	12.062481497503656
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.316962989	11.891231113854122
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.31666669999999997	11.880115491217524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.31044459999999996	11.646686252848271
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	11.463269794355597
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	11.254845070117122
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	10.421161179623311
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27370895	10.268506088514778
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.26637682	9.993432797901585
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.26171084999999994	9.818383566395536
PITUITARY APOPLEXY	0.26039801	9.769130863722697
BIOTINIDASE DEFICIENCY	0.25925926	9.726409347644042
LEPTOSPIROSIS	0.25910768	9.720722649591615
SHEEHAN SYNDROME	0.25666667	9.629145351709592
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25508440000000004	9.569784672679281
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.25220834000000003	9.461885973638076
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.2511494	9.422158621509578
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.250541419	9.399349514974325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.250541419	9.399349514974325
ARGININOSUCCINIC ACIDURIA	0.250541419	9.399349514974325
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.250541419	9.399349514974325
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
PALLISTER-HALL SYNDROME	0.25	9.379037558430934
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.25	9.379037558430934
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	9.379037558430934
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	9.379037558430934
LENNOX-GASTAUT SYNDROME	0.24200527	9.079106066672876
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23944559	8.983076727242619
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951174
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.2272471	8.525436343778042
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.222584759	8.350523258381191
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.217433909	8.157283195949816
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21630151	8.114799944941298
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.21429598000000002	8.039560180163058
AICARDI-GOUTIÈRES SYNDROME	0.20983932900000002	7.872363791707783
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20704225	7.767428155728188
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.20684932	7.760190164863596
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.204462989	7.6706642125602045
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424822	7.662606906490657
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.200541419	7.52354200328814
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.200541419	7.52354200328814
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.200541419	7.52354200328814
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744748
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	7.503230046744748
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744748
BRAIN-LUNG-THYROID SYNDROME	0.2	7.503230046744748
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	7.503230046744748
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	7.503230046744748
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.2	7.503230046744748
MEDULLARY SPONGE KIDNEY	0.2	7.503230046744748
SHOX-RELATED SHORT STATURE	0.2	7.503230046744748
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.19652777999999999	7.372965719580206
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	7.294801570891249
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	7.294801570891249
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	7.294801570891249
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	7.294801570891249
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	7.294801570891249
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	7.294801570891249
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	7.294801570891249
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.19195567	7.201437753935096
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175	7.105249346027848
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.86452884386067
UNILATERAL POLYMICROGYRIA	0.18170029999999998	6.816695752312672
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18159240000000001	6.812647759702455
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.7806787474422885
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.7806787474422885
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.18016861999999997	6.759233015322683
HEREDITARY FRUCTOSE INTOLERANCE	0.177625119	6.663810649687056
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.173875089	6.523123960826085
KIKUCHI-FUJIMOTO DISEASE	0.17058857000000002	6.399826420276098
CRYPTOSPORIDIOSIS	0.166667	6.252704211004034
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.166667	6.252704211004034
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	6.252704211004034
DRACUNCULIASIS	0.166667	6.252704211004034
PRIMARY MYELOFIBROSIS	0.166667	6.252704211004034
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.16574656999999998	6.218173220844407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.16406004	6.154901107990725
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.15486339999999998	5.809878580105252
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.70681646315218
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15159150000000002	5.6871294881555325
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.148148	5.557942624825704
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.3594446739390715
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.13835809999999998	5.190663265652572
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13624340000000001	5.111327862753317
PROPIONIC ACIDEMIA	0.135778039	5.0938693095644
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968417
FAMILIAL HYPOALDOSTERONISM	0.1316933	4.940625627574851
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.130079	4.88006330625255
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.12901942	4.840311943787901
COLCHICINE POISONING	0.12856995	4.823449559742349
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.1270754	4.767379797410538
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12429182999999999	4.66295096710445
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.12280404	4.607134813948219
PEHO-LIKE SYNDROME; PEHOL	0.12260529999999999	4.599678854250768
COG8-CDG	0.12224065899999999	4.585998927713393
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12197001900000001	4.575845556814139
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	4.559251450758907
GALACTOSEMIA	0.12152769999999999	4.559251450758907
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	4.559251450758907
TIGLIC ACIDEMIA	0.1213235	4.551590652881181
PYRUVATE CARBOXYLASE DEFICIENCY	0.12109965900000001	4.543193000296715
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12037025999999999	4.515828757832387
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.425523257443287
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.11544029899999998	4.330875600309987
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.11538375899999999	4.328754437175773
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.11369860000000001	4.265533758964062
PEHO SYNDROME; PEHO	0.11165241899999999	4.1887689251626705
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.11165241899999999	4.1887689251626705
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.11165241899999999	4.1887689251626705
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.1114943	4.182836909003865
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	4.168456968619277
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.11111099999999999	4.168456968619277
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	4.168456968619277
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	4.168456968619277
SAY-BARBER-MILLER SYNDROME	0.11111099999999999	4.168456968619277
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	4.168456968619277
RENAL AGENESIS, BILATERAL	0.11111099999999999	4.168456968619277
ENTERIC ANENDOCRINOSIS	0.11111099999999999	4.168456968619277
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11095811900000001	4.162721462055396
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	4.1424095055120045
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.10835452900000002	4.065044788468376
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.107583669	4.036125088899207
OCULOCEREBRORENAL SYNDROME OF LOWE	0.10739073900000001	4.028887098034615
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10666667	4.001722816651033
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331000000002	3.984714494781073
GLYCOGEN STORAGE DISEASE 0, LIVER	0.10437353900000002	3.9156933695494245
BILATERAL POLYMICROGYRIA	0.10411521	3.9060018599756963
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.10373134	3.891600535385477
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390427
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.8154900207603113
PFAPA SYNDROME	0.10071302000000001	3.778364788812024
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.100541419	3.7719269799157664
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.100541419	3.7719269799157664
LOWE OCULOCEREBRORENAL SYNDROME	0.100541419	3.7719269799157664
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.1	3.751615023372374
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	3.751615023372374
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	3.751615023372374
X-LINKED ACROGIGANTISM	0.1	3.751615023372374
NON-FUNCTIONING PARAGANGLIOMA	0.1	3.751615023372374
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	3.751615023372374
PARAGANGLIOMAS 1	0.1	3.751615023372374
RABSON-MENDENHALL SYNDROME	0.1	3.751615023372374
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	3.751615023372374
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.1	3.751615023372374
PARAGANGLIOMAS 3	0.1	3.751615023372374
LI-FRAUMENI SYNDROME	0.1	3.751615023372374
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1	3.751615023372374
PARAGANGLIOMAS 4	0.1	3.751615023372374
CARNEY COMPLEX	0.1	3.751615023372374
SAY SYNDROME	0.1	3.751615023372374
RAVINE SYNDROME	0.1	3.751615023372374
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755	3.6918724299326797
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810905
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810905
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.0978483	3.6708915229144705
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0978483	3.6708915229144705
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.0978483	3.6708915229144705
HEPATOCELLULAR CARCINOMA	0.09765288000000001	3.6635601168357965
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.09764164	3.6631384353071694
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.09758363900000001	3.6609624610774634
BETA-KETOTHIOLASE DEFICIENCY	0.094872149	3.5592377948802234
INFANTILE LIVER FAILURE SYNDROME 2	0.09446295900000001	3.5438865613660866
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.09382909	3.5201062367335854
CITRULLINEMIA TYPE I	0.09367863900000001	3.5144618944147723
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.09330630000000001	3.5004931685528975
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.09330630000000001	3.5004931685528975
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.09330630000000001	3.5004931685528975
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.09330630000000001	3.5004931685528975
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.09330630000000001	3.5004931685528975
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.09145080000000001	3.4308819517942233
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.09145051900000001	3.4308714097560076
BETA-THALASSEMIA	0.0909091	3.4105594532126147
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.0909091	3.4105594532126147
ULNAR-MAMMARY SYNDROME	0.0909091	3.4105594532126147
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0909091	3.4105594532126147
MACHADO-JOSEPH DISEASE TYPE 3	0.0909091	3.4105594532126147
MACHADO-JOSEPH DISEASE TYPE 2	0.0909091	3.4105594532126147
SPINOCEREBELLAR ATAXIA TYPE 3	0.0909091	3.4105594532126147
MACHADO-JOSEPH DISEASE TYPE 1	0.0909091	3.4105594532126147
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0909091	3.4105594532126147
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.090350999	3.389621652251023
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	3.3778941412041115
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.088945789	3.3369035827810922
CITRULLINEMIA TYPE II	0.08779628900000001	3.293778768087427
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.08760605900000001	3.2866420708284663
ACUTE BILIRUBIN ENCEPHALOPATHY	0.08760605900000001	3.2866420708284663
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08760605900000001	3.2866420708284663
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.08725487000000001	3.2734668115440346
HEPATIC VENO-OCCLUSIVE DISEASE	0.08725487000000001	3.2734668115440346
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.087167039	3.270171730552856
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.08635400000000001	3.2396696372829803
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.08502421900000001	3.1897813735090286
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.08502421900000001	3.1897813735090286
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.08502421900000001	3.1897813735090286
GLYCEROL KINASE DEFICIENCY; GKD	0.084291489	3.162292164748272
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.084291489	3.162292164748272
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08387471900000001	3.146656558815363
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.083856129	3.1459591335825183
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.08361622899999999	3.1369590091414468
PATENT DUCTUS VENOSUS	0.08333330000000001	3.126344602271971
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.08333330000000001	3.126344602271971
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08113734	3.043960637004722
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.08113734	3.043960637004722
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.965381934855681
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07840243999999999	2.9413577177305106
WOLCOTT-RALLISON SYNDROME	0.077796359	2.9186198918807054
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07692310000000001	2.8858585760437547
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.8858585760437547
MAPLE SYRUP URINE DISEASE; MSUD	0.076750339	2.8793772484132263
LYSOSOMAL ACID LIPASE DEFICIENCY	0.07644366999999999	2.8678722081372
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07515994000000001	2.819711600597662
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07461872	2.799407109768166
GLYCOGEN STORAGE DISEASE IXC	0.07346382	2.7560797078632384
METHYLMALONIC ACIDURIA, CBLA TYPE	0.073458119	2.755865828290756
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.07324301899999999	2.7477961043754817
GLYCOGEN STORAGE DISEASE IXA	0.07308824	2.7419893921584566
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0729167	2.7355538717473635
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7346876238384668
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.07204304	2.7027775119341686
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07197001900000001	2.700038045127952
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07197001900000001	2.700038045127952
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.07197001900000001	2.700038045127952
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6835377294483056
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6797260885845593
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6797260885845593
SILVER-RUSSELL SYNDROME	0.07142860000000001	2.6797260885845593
TEMPLE SYNDROME	0.07142860000000001	2.6797260885845593
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	2.6797260885845593
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.6797260885845593
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6553706038528255
HYDROXYKYNURENINURIA	0.07068150000000001	2.6516977727449444
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07019114000000001	2.633301353316336
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.069708089	2.6151791394297854
SHORT STATURE DUE TO GHSR DEFICIENCY	0.06916667	2.5948671828863925
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.067208119	2.5213898893299826
XP21 MICRODELETION SYNDROME	0.067208119	2.5213898893299826
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.50107793278659
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.50107793278659
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.50107793278659
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0666667	2.50107793278659
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	2.50107793278659
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.50107793278659
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.50107793278659
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	2.50107793278659
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.06665754	2.5007342848504495
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06549017	2.4569390565521076
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.4519137307121497
ACQUIRED METHEMOGLOBINEMIA	0.06474125900000001	2.4288427989644195
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.06433827	2.413724203097881
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.06389694900000001	2.3971675381605837
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06348501	2.3817131727494534
ALAGILLE SYNDROME 1; ALGS1	0.06307467	2.3663187956625475
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.06274507	2.3539534725455122
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.06274507	2.3539534725455122
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.348430344908104
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06240754999999999	2.3412910215186256
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.06096382	2.287127829941692
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059887489	2.2467480344444777
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.05979277	2.2431945422104898
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.05979277	2.2431945422104898
VICI SYNDROME; VICIS	0.059364919	2.227143219816841
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.059140269999999995	2.2187152541829844
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.058958079999999996	2.2118801867719027
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	2.206831263273448
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	2.206831263273448
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	2.206831263273448
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	2.206831263273448
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.1676047517505688
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.056584159	2.122819809892911
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246626
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246626
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246626
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.055555600000000004	2.0842322359246626
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.055229069	2.0719820498726946
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.054462989	2.0432416775016433
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.054462989	2.0432416775016433
KEARNS-SAYRE SYNDROME; KSS	0.053038169	1.9897879163256291
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.052845239	1.9825499254610368
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.05241194	1.9662942150809142
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.050735659999999995	1.903406642767128
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.050541419000000004	1.8961194682295794
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.050541419000000004	1.8961194682295794
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.050541419000000004	1.8961194682295794
KAPOSI SARCOMA	0.0502023	1.8833970288784692
OSTEOPETROSIS AND RELATED DISORDERS	0.04918584	1.8452633628118984
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.048710929	1.8274465303882503
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.8207075418379168
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.046509089999999996	1.7448420076737783
VICI SYNDROME	0.045995919	1.7255898073421883
DILATED CARDIOMYOPATHY WITH ATAXIA	0.045795109	1.7180561892137542
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	1.7052778507987958
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	1.7052778507987958
ALAGILLE SYNDROME 2	0.0454545	1.7052778507987958
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	1.7052778507987958
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.04513573	1.6933188275887916
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607514
COG2-CDG	0.041666699999999994	1.5631741769434964
DISTAL MONOSOMY 12Q	0.041666699999999994	1.5631741769434964
HYPOTONIA-CYSTINURIA SYNDROME	0.04152505	1.5578600142628898
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.04152505	1.5578600142628898
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.556034853554019
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.041459989	1.5554191760125335
NEONATAL ADRENOLEUKODYSTROPHY	0.041366299	1.551904287897136
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	1.5315923313537436
BLAU SYNDROME	0.04076834	1.5294711682195288
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.040763049999999995	1.529272707784792
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0407256	1.5278677279585393
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.4743978348379245
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4743978348379245
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.038022569000000006	1.4264604108761272
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.038022569	1.426460410876127
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.03767925	1.413580403694035
SLC39A8-CDG	0.037578419	1.4097976127498186
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.037578419	1.4097976127498186
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.389485656206426
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.037037	1.389485656206426
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.037037	1.389485656206426
LISSENCEPHALY 2; LIS2	0.037037	1.389485656206426
RHYNS SYNDROME	0.037037	1.389485656206426
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.389485656206426
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.389485656206426
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
CANAVAN DISEASE	0.037037	1.389485656206426
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.389485656206426
BENIGN SCHWANNOMA	0.037037	1.389485656206426
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.389485656206426
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.389485656206426
FANCONI ANEMIA	0.037037	1.389485656206426
TRICHOTHIODYSTROPHY	0.037037	1.389485656206426
POLAND SYNDROME	0.037037	1.389485656206426
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.389485656206426
ATRANSFERRINEMIA	0.037037	1.389485656206426
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.389485656206426
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.389485656206426
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	1.389485656206426
SITOSTEROLEMIA	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037037	1.389485656206426
BURKITT LYMPHOMA	0.037037	1.389485656206426
JEUNE SYNDROME	0.037037	1.389485656206426
16P13.11 MICRODELETION SYNDROME	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.389485656206426
CHRISTIANSON SYNDROME	0.037037	1.389485656206426
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.036885480000000005	1.3838012091230125
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3726183575451936
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036220379	1.3588491800864122
SLC35A2-CDG	0.03617967	1.3573219351265475
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03604598	1.352306401001801
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.035714300000000004	1.3398630442922796
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03566625	1.338060393273549
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03566625	1.338060393273549
JUVENILE ABSENCE EPILEPSY	0.03566625	1.338060393273549
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.035437929	1.3294946683360351
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.035024219	1.3139738618228414
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457724
ALPERS-HUTTENLOCHER SYNDROME	0.034820050000000005	1.3063142269457724
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.034627120000000004	1.29907623608118
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.293661905279449
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.293661905279449
MODY	0.0344828	1.293661905279449
MELAS	0.03446908	1.293147183698242
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.278147101350292
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.034069249999999995	1.278147101350292
DOORS SYNDROME	0.034069249999999995	1.278147101350292
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.278147101350292
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.033908069000000006	1.2721002107394708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.0338934	1.271549886331692
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.03374223	1.26587856990086
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.03332238	1.2501274142252312
MENINGIOMA	0.03315414	1.2438156971099095
GANGLIOCYTOMA	0.03315414	1.2438156971099095
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
CHROMOSOME 1P36 DELETION SYNDROME	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
BENIGN OCCIPITAL EPILEPSY	0.03240334	1.2156485715144298
PEHO SYNDROME	0.0322581	1.2101997258544837
ALG13-CDG	0.0322581	1.2101997258544837
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.2101997258544837
AICARDI SYNDROME	0.0322581	1.2101997258544837
WEST SYNDROME	0.0322581	1.2101997258544837
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.031621939	1.1863334142056476
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.03158369	1.184898458975358
EPILEPSY, PYRIDOXINE-DEPENDENT	0.03158369	1.184898458975358
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.031516359	1.1823724590639713
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.17151344689497
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.03108052	1.1660214576622552
CHROMOSOME 17Q12 DELETION SYNDROME	0.030948569999999998	1.1610712016389155
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.030533619	1.1455038375832816
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.030533618999999998	1.1455038375832816
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.030462299999999998	1.1428282232647624
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.030195999	1.1328376349413718
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.029981879999999995	1.1248047143694768
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.0941742408335005
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.029050318999999998	1.0898561319415991
FUMARASE DEFICIENCY; FMRD	0.02895325	1.0862144767545618
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.02805236	1.0524165521705022
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02805236	1.0524165521705022
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.027965509	1.0491582370065533
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.02794327	1.0483239153415056
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.02785426	1.0449846028092018
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623313
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.027777800000000002	1.0421161179623313
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623313
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623313
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.027777579999999996	1.0421078644092796
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.027605868999999998	1.0356659287364967
NEUROLEPTIC MALIGNANT SYNDROME	0.027503569999999998	1.031828064083737
WALDENSTRÖM MACROGLOBULINEMIA	0.02723386	1.0217095832041996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668514
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.0139489923668514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668514
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.026727849999999997	1.0027260360244328
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.026699979999999998	1.001680460917419
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.02665294	0.9999157012104248
RIDDLE SYNDROME	0.02665294	0.9999157012104248
MARSILI SYNDROME; MARSIS	0.02665294	0.9999157012104248
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.02665294	0.9999157012104248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.026517330000000002	0.9948281360772295
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.026304599999999997	0.9868473254380092
AMISH INFANTILE EPILEPSY SYNDROME	0.025385869999999998	0.9523801127337803
SALT-AND-PEPPER SYNDROME	0.025385869999999998	0.9523801127337803
LEISHMANIASIS	0.02519817	0.9453383313349104
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.02519817	0.9453383313349104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.025021229	0.9387001861964052
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.02500794	0.9382016340759491
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.02500794	0.9382016340759491
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.024667039	0.9254123409451226
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	0.9119527092419196
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0241153	0.904713217731318
PRIMARY HYPEROXALURIA TYPE 1	0.0241153	0.904713217731318
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.024043939	0.9020360277344893
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.024043939	0.9020360277344893
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.02393269	0.8978623935371377
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.023866949	0.8953960443046225
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.023866949	0.8953960443046225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.023866949	0.8953960443046225
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.023866949	0.8953960443046225
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.023866949	0.8953960443046225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.023866949	0.8953960443046225
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.023866949	0.8953960443046225
ABETAL34V AMYLOIDOSIS	0.02350252	0.8817240711910969
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02340734	0.8781532840118509
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.023347699	0.8759157832957615
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.023325529999999997	0.87508408776123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.023325529999999997	0.87508408776123
ISOLATED COMPLEX I DEFICIENCY	0.023142879999999998	0.8682317629210403
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818612
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818612
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818612
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8241416576818612
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818612
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.021818019	0.818528078606239
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.021818019	0.818528078606239
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.021818019	0.818528078606239
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.021818019	0.818528078606239
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.021818019	0.818528078606239
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.021818019	0.818528078606239
KRABBE DISEASE	0.021818019	0.818528078606239
GITELMAN SYNDROME	0.021818019	0.818528078606239
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.021546359	0.8083364412337455
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.021356129	0.8011997439747844
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.02129822	0.7990272212308994
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0212766	0.7982161220628465
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0212766	0.7982161220628465
IMMUNODEFICIENCY 61; IMD61	0.0212766	0.7982161220628465
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.0212766	0.7982161220628465
H SYNDROME	0.0212766	0.7982161220628465
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0212766	0.7982161220628465
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.0212766	0.7982161220628465
STÜVE-WIEDEMANN SYNDROME	0.0212766	0.7982161220628465
NAKAJO-NISHIMURA SYNDROME	0.0212766	0.7982161220628465
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0212766	0.7982161220628465
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0212766	0.7982161220628465
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0212766	0.7982161220628465
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.0212766	0.7982161220628465
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0212766	0.7982161220628465
CAROLI DISEASE, ISOLATED	0.0212766	0.7982161220628465
DOHLE BODIES AND LEUKEMIA	0.0212766	0.7982161220628465
MAJEED SYNDROME	0.0212766	0.7982161220628465
IMMUNODEFICIENCY 9; IMD9	0.0212766	0.7982161220628465
YAO SYNDROME	0.0212766	0.7982161220628465
STUVE-WIEDEMANN SYNDROME	0.0212766	0.7982161220628465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.02120304	0.7954564340516538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02120304	0.7954564340516538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02120304	0.7954564340516538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.02120304	0.7954564340516538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.02120304	0.7954564340516538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.02120304	0.7954564340516538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.02120304	0.7954564340516538
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.02118759	0.7948768095305427
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.02118759	0.7948768095305427
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.021099659	0.7915779769243412
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.021099659	0.7915779769243412
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870419
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870419
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870419
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870419
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870419
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.020928259999999997	0.7851477462904309
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.020928259999999997	0.7851477462904309
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.020928259999999997	0.7851477462904309
CADASIL	0.020743349	0.7782105974345631
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751289
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.020740849999999998	0.7781168445751289
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.02055824	0.7712660203809486
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.020547919999999997	0.7708788537105365
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.020392079	0.7650322993419629
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.020392079	0.7650322993419629
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.020365269999999998	0.7640265288703469
GAUCHER DISEASE	0.020032849999999998	0.7515554102096524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.019684119	0.7384723656224959
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.019616359	0.7359302712826588
SNEDDON SYNDROME	0.019616359	0.7359302712826588
ABETA AMYLOIDOSIS, DUTCH TYPE	0.019616359	0.7359302712826588
ENCEPHALITIS LETHARGICA	0.019083059	0.7159229083630138
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.01907494	0.7156183147392662
POLYCYTHEMIA VERA	0.01907494	0.7156183147392662
SECONDARY POLYCYTHEMIA	0.01907494	0.7156183147392662
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.018968	0.7116063376332719
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.018968	0.7116063376332719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.018968	0.7116063376332719
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.018968	0.7116063376332719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.018968	0.7116063376332719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.018885039	0.7084939602937318
GAUCHER DISEASE TYPE 2	0.01869322	0.7012976498720492
GAUCHER DISEASE TYPE 3	0.01869322	0.7012976498720492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01869322	0.7012976498720492
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.01853655	0.6954199946149318
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.01853655	0.6954199946149318
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.018000369000000002	0.6753045476664635
HISTIOCYTOID CARDIOMYOPATHY	0.017981679	0.6746033708185952
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.017813139999999998	0.6682804363743535
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.017813139999999998	0.6682804363743535
LIVER FAILURE, INFANTILE, TRANSIENT	0.017813139999999998	0.6682804363743535
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.017813139999999998	0.6682804363743535
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.017807439	0.6680665568018712
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.017807439	0.6680665568018712
GLYCOGEN STORAGE DISEASE IA	0.01763049	0.6614281115341639
GLYCOGEN STORAGE DISEASE IB	0.01763049	0.6614281115341639
NAVAJO NEUROHEPATOPATHY	0.01763049	0.6614281115341639
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.017628289000000002	0.6613455384874997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.01748648	0.6560254107390054
AMISH LETHAL MICROCEPHALY	0.01745895	0.6549925911230711
PEARSON SYNDROME	0.01745895	0.6549925911230711
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01745683	0.6549130568845756
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.017292409	0.6487446139469966
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	0.6477546002584788
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
MOSAIC TRISOMY 15	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397245
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397245
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.017194659	0.64507741026165
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.017194659	0.64507741026165
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.017099479	0.6415066230824041
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.017099479	0.6415066230824041
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.017099479	0.6415066230824041
PRIMARY SCLEROSING CHOLANGITIS	0.01708687	0.6410335819441071
RIBOFLAVIN DEFICIENCY	0.01708337	0.6409022754182891
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.017017629	0.6384359261857738
ETHYLMALONIC ENCEPHALOPATHY	0.017017629	0.6384359261857738
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.017017629	0.6384359261857738
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.017017629	0.6384359261857738
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016649999000000002	0.6246438638753501
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.016476209999999998	0.6181239696423813
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.016476209999999998	0.6181239696423813
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.016476209999999998	0.6181239696423813
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
PERMANENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.01610858	0.6043319073319575
PYRIDOXINE-DEPENDENT EPILEPSY	0.01528218	0.5733285607788082
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	0.5695049147469872
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.015043649000000001	0.564379795947408
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
HAREL-YOON SYNDROME; HAYOS	0.014925399999999998	0.5599435486984202
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984202
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984202
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.014925399999999998	0.5599435486984202
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984202
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.014925399999999998	0.5599435486984202
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984202
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.014925399999999998	0.5599435486984202
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.014432989	0.5414701836456821
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.014432989	0.5414701836456821
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014432989	0.5414701836456821
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.014432989	0.5414701836456821
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.014432988999999999	0.541470183645682
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014432988999999999	0.541470183645682
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.014432988999999999	0.541470183645682
LEIGH SYNDROME; LS	0.014432988999999999	0.541470183645682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.014432988999999999	0.541470183645682
PRIMARY HYPEROXALURIA	0.01433827	0.5379166914116941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.014250338999999999	0.5346178588054924
2P21 MICRODELETION SYNDROME	0.014250338999999999	0.5346178588054924
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.014250338999999999	0.5346178588054924
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.014240018999999998	0.5342306921350803
CITRULLINEMIA, CLASSIC	0.014240018999999998	0.5342306921350803
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014240018999999998	0.5342306921350803
CEDNIK SYNDROME	0.014240018999999998	0.5342306921350803
PRADER-WILLI SYNDROME	0.014240018999999998	0.5342306921350803
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.014240018999999998	0.5342306921350803
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014240018999999998	0.5342306921350803
STURGE-WEBER SYNDROME	0.014240018999999998	0.5342306921350803
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.014240018999999998	0.5342306921350803
PITT-HOPKINS-LIKE SYNDROME	0.014171729	0.5316687142356195
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.01414804	0.5307799941527328
IMMUNOGLOBULIN A VASCULITIS	0.014076679000000002	0.5281028041559042
TAKAYASU ARTERITIS	0.014076679000000002	0.5281028041559042
VIRAL HEMORRHAGIC FEVER	0.014076679000000002	0.5281028041559042
BEHÇET DISEASE	0.014076679000000002	0.5281028041559042
RABIES	0.014076679	0.528102804155904
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.013891569999999999	0.5211582271022897
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	0.5211582271022897
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.013891569999999999	0.5211582271022897
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01370892	0.5143059022620999
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013706719	0.5142233292154356
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.013706719	0.5142233292154356
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.013698599999999998	0.5139187355916879
WILLIAMS SYNDROME	0.013698599999999998	0.5139187355916879
SICKLE CELL ANEMIA	0.013698599999999998	0.5139187355916879
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	0.5139187355916879
STROKE, ISCHEMIC	0.013698599999999998	0.5139187355916879
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.013698599999999998	0.5139187355916879
19P13.3 MICRODUPLICATION SYNDROME	0.013698599999999998	0.5139187355916879
EISENMENGER SYNDROME	0.013698599999999998	0.5139187355916879
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.5139187355916879
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, IOWA TYPE	0.013698599999999998	0.5139187355916879
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.013698599999999998	0.5139187355916879
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
AYMÉ-GRIPP SYNDROME	0.013698599999999998	0.5139187355916879
ACYS AMYLOIDOSIS	0.013698599999999998	0.5139187355916879
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.5139187355916879
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.5139187355916879
AMYLOIDOSIS VI	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.5139187355916879
AORTA COARCTATION	0.013698599999999998	0.5139187355916879
WILLIAMS-BEUREN SYNDROME; WBS	0.013698599999999998	0.5139187355916879
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916879
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5139187355916879
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.5139187355916879
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	0.5139187355916879
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.5139187355916879
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916879
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5139187355916879
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.5139187355916879
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.5139187355916879
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.5139187355916879
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.5139187355916879
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	0.5139187355916879
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.5139187355916879
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.5139187355916879
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.5139187355916879
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.5139187355916879
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5139187355916879
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013698599999999998	0.5139187355916879
FAMILIAL AORTIC DISSECTION	0.013698599999999998	0.5139187355916879
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	0.5139187355916879
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
KAWASAKI DISEASE	0.01353526	0.5077908476125116
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.01353526	0.5077908476125116
RHEUMATIC FEVER	0.01353526	0.5077908476125116
CINCA SYNDROME	0.01353526	0.5077908476125116
LEGIONELLOSIS	0.01353526	0.5077908476125116
CLASSIC HODGKIN LYMPHOMA	0.01353526	0.5077908476125116
KERION CELSI	0.01353526	0.5077908476125116
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01353526	0.5077908476125116
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.013355530000000001	0.5010480699310044
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.013180830000000001	0.49449399848517284
LETTERER-SIWE DISEASE	0.0131653	0.49391137267204305
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.013029250000000001	0.48880730043274506
MARBURG HEMORRHAGIC FEVER	0.013029250000000001	0.48880730043274506
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.013029250000000001	0.48880730043274506
RELAPSING FEVER	0.013029250000000001	0.48880730043274506
KRABBE DISEASE	0.0129906	0.48735730122621157
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.01241859	0.4658976881310193
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748832
INFANTILE LIVER FAILURE SYNDROME 1	0.011505238999999999	0.4316322747988974
PSEUDO-TORCH SYNDROME 2	0.011505238999999999	0.4316322747988974
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.011494299999999999	0.4312218856314908
WRINKLY SKIN SYNDROME	0.011494299999999999	0.4312218856314908
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
PERLMAN SYNDROME	0.011494299999999999	0.4312218856314908
DESMOSTEROLOSIS	0.011494299999999999	0.4312218856314908
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.011494299999999999	0.4312218856314908
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
RING CHROMOSOME 14 SYNDROME	0.011494299999999999	0.4312218856314908
BETA-UREIDOPROPIONASE DEFICIENCY	0.011494299999999999	0.4312218856314908
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.011494299999999999	0.4312218856314908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.4312218856314908
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.011312309	0.4243942839343051
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011129659	0.4175419590941155
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.011129659	0.4175419590941155
CONGENITAL DISORDER OF GLYCOSYLATION	0.011129659	0.4175419590941155
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.011129659	0.4175419590941155
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.010963819999999999	0.4113203182555049
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.010963819999999999	0.4113203182555049
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.010963819999999999	0.4113203182555049
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.010963819999999999	0.4113203182555049
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010958119	0.41110643868302255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010958119	0.41110643868302255
SUDDEN CARDIAC FAILURE, INFANTILE	0.010958119	0.41110643868302255
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010958119	0.41110643868302255
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010958119	0.41110643868302255
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010958119	0.41110643868302255
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010958119	0.41110643868302255
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.010958119	0.41110643868302255
ISOVALERIC ACIDEMIA	0.010958119	0.41110643868302255
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075843
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.01077359	0.40418362099654365
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.01077359	0.40418362099654365
TYROSINEMIA, TYPE I; TYRSN1	0.01058824	0.39723000255072305
GLYCOGEN STORAGE DISEASE VI	0.01058824	0.39723000255072305
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.01058824	0.39723000255072305
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.01058824	0.39723000255072305
MICROVILLUS INCLUSION DISEASE	0.010416700000000001	0.3907944821396301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	0.3907944821396301
HAWKINSINURIA	0.010416700000000001	0.3907944821396301
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	0.3907944821396301
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.3907944821396301
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.3907944821396301
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010416700000000001	0.3907944821396301
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.3907944821396301
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.3907944821396301
HAWKINSINURIA	0.010416700000000001	0.3907944821396301
BENIGN FAMILIAL INFANTILE EPILEPSY	0.010345339	0.3881172921428013
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.010345339	0.3881172921428013
LYNCH SYNDROME	0.010345339	0.3881172921428013
EPISODIC ATAXIA, TYPE 6	0.010345339	0.3881172921428013
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.010345339	0.3881172921428013
MALAN OVERGROWTH SYNDROME	0.010345339	0.3881172921428013
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.010345339	0.3881172921428013
FAMILIAL COLORECTAL CANCER TYPE X	0.010345339	0.3881172921428013
SYSTEMIC SCLEROSIS	0.010345339	0.3881172921428013
ATYPICAL TERATOID RHABDOID TUMOR	0.010345339	0.3881172921428013
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.010345339	0.3881172921428013
EPENDYMOMA	0.010345339	0.3881172921428013
MALIGNANT ATROPHIC PAPULOSIS	0.010345339	0.3881172921428013
CYCLIC VOMITING SYNDROME	0.010345339	0.3881172921428013
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.010345339	0.3881172921428013
SNEDDON SYNDROME	0.010345339	0.3881172921428013
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.010345339	0.3881172921428013
DISTAL 16P11.2 MICRODELETION SYNDROME	0.010345339	0.3881172921428013
SUBEPENDYMOMA	0.010345339	0.3881172921428013
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.010345339	0.3881172921428013
SAETHRE-CHOTZEN SYNDROME	0.010345339	0.3881172921428013
NORRIE DISEASE	0.010345339	0.3881172921428013
BERNARD-SOULIER SYNDROME	0.010345339	0.3881172921428013
PHACE ASSOCIATION	0.010345339	0.3881172921428013
PULMONARY ARTERIOVENOUS MALFORMATION	0.010345339	0.3881172921428013
EPISODIC ATAXIA TYPE 6	0.010345339	0.3881172921428013
HARTNUP DISEASE	0.010345339	0.3881172921428013
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010250159	0.38454650496355547
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.010250159	0.38454650496355547
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.010250159	0.38454650496355547
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.010250159	0.38454650496355547
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.010250159	0.38454650496355547
RAYNAUD-CLAES SYNDROME; MRXSRC	0.010250159	0.38454650496355547
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.010250159	0.38454650496355547
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.010250159	0.38454650496355547
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.010250159	0.38454650496355547
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.010250159	0.38454650496355547
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010250159	0.38454650496355547
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010250159	0.38454650496355547
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.010250159	0.38454650496355547
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.010250159	0.38454650496355547
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.009975379	0.37423781720233285
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.009975379	0.37423781720233285
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.009975379	0.37423781720233285
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.009975379	0.37423781720233285
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.009975379	0.37423781720233285
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.009975379	0.37423781720233285
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.009975379	0.37423781720233285
FADD-RELATED IMMUNODEFICIENCY	0.009975379	0.37423781720233285
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.009975379	0.37423781720233285
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.009975379	0.37423781720233285
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.009975379	0.37423781720233285
HYPEREKPLEXIA 4; HKPX4	0.009975379	0.37423781720233285
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.009975379	0.37423781720233285
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.009975379	0.37423781720233285
GLUTAMINE DEFICIENCY, CONGENITAL	0.009975379	0.37423781720233285
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.009975379	0.37423781720233285
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.009975379	0.37423781720233285
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.009975379	0.37423781720233285
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.009975379	0.37423781720233285
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009975379	0.37423781720233285
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.009975379	0.37423781720233285
GLYCINE ENCEPHALOPATHY; GCE	0.009975379	0.37423781720233285
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.009975379	0.37423781720233285
PITT-HOPKINS SYNDROME	0.009975379	0.37423781720233285
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.009975379	0.37423781720233285
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.009975379	0.37423781720233285
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.009839328999999999	0.3691337449630347
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00980392	0.36780533559940887
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.36780533559940887
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.36780533559940887
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.36780533559940887
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.36780533559940887
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.36780533559940887
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00980392	0.36780533559940887
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.36780533559940887
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.36780533559940887
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.36780533559940887
EPISODIC ATAXIA, TYPE 2	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.36780533559940887
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.36780533559940887
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00980392	0.36780533559940887
ACROMEGALY	0.00980392	0.36780533559940887
EPISODIC ATAXIA TYPE 7	0.00980392	0.36780533559940887
BLACKFAN-DIAMOND ANEMIA	0.00980392	0.36780533559940887
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.36780533559940887
STORMORKEN SYNDROME; STRMK	0.00980392	0.36780533559940887
VON HIPPEL-LINDAU DISEASE	0.00980392	0.36780533559940887
SOMATOMAMMOTROPINOMA	0.00980392	0.36780533559940887
FAMILIAL CERVICAL ARTERY DISSECTION	0.00980392	0.36780533559940887
CLASSICAL EHLERS-DANLOS SYNDROME	0.00980392	0.36780533559940887
ARACHNOIDITIS	0.00980392	0.36780533559940887
VASCULAR EHLERS-DANLOS SYNDROME	0.00980392	0.36780533559940887
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.36780533559940887
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565013
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.009800679	0.3676837457565013
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00970874	0.364234548420163
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00970874	0.364234548420163
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00970874	0.364234548420163
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00970874	0.364234548420163
NIPAH VIRUS DISEASE	0.009649099000000001	0.36199704770407354
LASSA FEVER	0.009649099	0.3619970477040735
NOCARDIOSIS	0.009649099	0.3619970477040735
RIFT VALLEY FEVER	0.009649099	0.3619970477040735
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.009649099	0.3619970477040735
POSTENCEPHALITIC PARKINSONISM	0.009649099	0.3619970477040735
LUJO HEMORRHAGIC FEVER	0.009649099	0.3619970477040735
CRYPTOCOCCOSIS	0.009649099	0.3619970477040735
SCRUB TYPHUS	0.009649099	0.3619970477040735
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.009649099	0.3619970477040735
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.009649099	0.3619970477040735
GRANULOMATOSIS WITH POLYANGIITIS	0.009649099	0.3619970477040735
ROSAÏ-DORFMAN DISEASE	0.009649099	0.3619970477040735
CENTRAL DIABETES INSIPIDUS	0.009649099	0.3619970477040735
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.00943396	0.3539258606589404
IMMUNODEFICIENCY 44	0.00943396	0.3539258606589404
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00943396	0.3539258606589404
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00943396	0.3539258606589404
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00943396	0.3539258606589404
MEDULLOBLASTOMA	0.00929791	0.34882178841964223
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00929791	0.34882178841964223
HELLP SYNDROME	0.00929791	0.34882178841964223
PREECLAMPSIA	0.00929791	0.34882178841964223
MERRF	0.00925926	0.34737178921310885
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
PAINE SYNDROME	0.00925926	0.34737178921310885
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
CARNOSINEMIA	0.00925926	0.34737178921310885
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.34737178921310885
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310885
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.34737178921310885
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.34737178921310885
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.34737178921310885
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
X-LINKED ADRENOLEUKODYSTROPHY	0.00916422	0.3438062542948958
POSTORGASMIC ILLNESS SYNDROME	0.00910768	0.341685091160681
TYPHOID	0.00910768	0.341685091160681
YELLOW FEVER	0.00910768	0.341685091160681
PAROXYSMAL COLD HEMOGLOBINURIA	0.00910768	0.341685091160681
HODGKIN LYMPHOMA	0.00910768	0.341685091160681
MAJEED SYNDROME	0.00910768	0.341685091160681
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00910768	0.341685091160681
BABESIOSIS	0.00910768	0.341685091160681
RHABDOID TUMOR	0.00910768	0.341685091160681
DENGUE FEVER	0.00910768	0.341685091160681
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00910768	0.341685091160681
LYME DISEASE	0.00910768	0.341685091160681
MALARIA	0.00910768	0.341685091160681
HUGHES-STOVIN SYNDROME	0.00910768	0.341685091160681
PONTIAC FEVER	0.00910768	0.341685091160681
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00910768	0.341685091160681
PLAGUE	0.00910768	0.341685091160681
AMERICAN TRYPANOSOMIASIS	0.00910768	0.341685091160681
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00910768	0.341685091160681
FAMILIAL COLD URTICARIA	0.00910768	0.341685091160681
GIANT CELL ARTERITIS	0.00910768	0.341685091160681
RAT-BITE FEVER	0.00910768	0.341685091160681
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.008194329	0.3074196778285592
RECURRENT ACUTE PANCREATITIS	0.008194329	0.3074196778285592
PMM2-CDG	0.008194329	0.3074196778285592
STEVENS-JOHNSON SYNDROME	0.007652910000000001	0.28710772128516676
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.007652910000000001	0.28710772128516676
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.007652910000000001	0.28710772128516676
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.007652910000000001	0.28710772128516676
BETA-THALASSEMIA MAJOR	0.007652910000000001	0.28710772128516676
ADULT-ONSET STILL DISEASE	0.007652910000000001	0.28710772128516676
BUDD-CHIARI SYNDROME	0.007652910000000001	0.28710772128516676
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0075836689999999995	0.28451006552683344
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0075836689999999995	0.28451006552683344
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0075836689999999995	0.28451006552683344
3-HYDROXYISOBUTYRIC ACIDURIA	0.0075836689999999995	0.28451006552683344
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0075836689999999995	0.28451006552683344
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0075836689999999995	0.28451006552683344
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0075836689999999995	0.28451006552683344
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0075836689999999995	0.28451006552683344
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0075836689999999995	0.28451006552683344
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.0075836689999999995	0.28451006552683344
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0075836689999999995	0.28451006552683344
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0075836689999999995	0.28451006552683344
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0075836689999999995	0.28451006552683344
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0075836689999999995	0.28451006552683344
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.007390739	0.2772720746622412
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007390739	0.2772720746622412
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.007390739	0.2772720746622412
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.007390739	0.2772720746622412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007390739	0.2772720746622412
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.007390739	0.2772720746622412
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.007390739	0.2772720746622412
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.007390739	0.2772720746622412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.007390739	0.2772720746622412
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.007390739	0.2772720746622412
PERRAULT SYNDROME 5; PRLTS5	0.007390739	0.2772720746622412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.007390739	0.2772720746622412
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.007208089000000001	0.2704197498220515
HOLOPROSENCEPHALY	0.007208089000000001	0.2704197498220515
ENDOCARDIAL FIBROELASTOSIS	0.007208089000000001	0.2704197498220515
GALACTOSEMIA	0.007208089000000001	0.2704197498220515
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.007208089000000001	0.2704197498220515
MEHMO SYNDROME; MEHMO	0.007208089000000001	0.2704197498220515
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.007208089000000001	0.2704197498220515
HOLOPROSENCEPHALY 1; HPE1	0.007208089000000001	0.2704197498220515
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.007208089000000001	0.2704197498220515
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.007208089000000001	0.2704197498220515
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007208089000000001	0.2704197498220515
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.007208089000000001	0.2704197498220515
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.007208089000000001	0.2704197498220515
PITUITARY STALK INTERRUPTION SYNDROME	0.007208089000000001	0.2704197498220515
MENKES DISEASE	0.007208089000000001	0.2704197498220515
SMITH-KINGSMORE SYNDROME; SKS	0.007208089000000001	0.2704197498220515
HYPOADRENOCORTICISM, FAMILIAL	0.007208089000000001	0.2704197498220515
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.007208089000000001	0.2704197498220515
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.007208089000000001	0.2704197498220515
SOTOS SYNDROME	0.007208089000000001	0.2704197498220515
MIRAGE SYNDROME; MIRAGE	0.007208089000000001	0.2704197498220515
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.007208089000000001	0.2704197498220515
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007208089000000001	0.2704197498220515
FRUCTOSE AND GALACTOSE INTOLERANCE	0.007208089000000001	0.2704197498220515
OCULODENTODIGITAL DYSPLASIA	0.007208089000000001	0.2704197498220515
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007208089000000001	0.2704197498220515
TENORIO SYNDROME; TNORS	0.007208089000000001	0.2704197498220515
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.007208089000000001	0.2704197498220515
TIMOTHY SYNDROME; TS	0.007208089000000001	0.2704197498220515
SHASHI-PENA SYNDROME; SHAPNS	0.007208089000000001	0.2704197498220515
VISCERAL STEATOSIS, CONGENITAL	0.007208089000000001	0.2704197498220515
SIMPSON-GOLABI-BEHMEL SYNDROME	0.007208089000000001	0.2704197498220515
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.264198108983441
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.264198108983441
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.264198108983441
OLIVER SYNDROME	0.00704225	0.264198108983441
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00704225	0.264198108983441
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00704225	0.264198108983441
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00704225	0.264198108983441
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.264198108983441
1Q44 MICRODELETION SYNDROME	0.00704225	0.264198108983441
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.264198108983441
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.264198108983441
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00704225	0.264198108983441
SUCCINIC ACIDEMIA	0.00704225	0.264198108983441
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.264198108983441
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00704225	0.264198108983441
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.264198108983441
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.264198108983441
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00704225	0.264198108983441
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.264198108983441
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.264198108983441
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.264198108983441
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00704225	0.264198108983441
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.264198108983441
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00704225	0.264198108983441
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.264198108983441
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.264198108983441
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.264198108983441
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.264198108983441
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00704225	0.264198108983441
SARCOSINEMIA	0.00704225	0.264198108983441
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.264198108983441
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
GRACILE SYNDROME	0.00704225	0.264198108983441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
X SMALL RINGS	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.264198108983441
W SYNDROME	0.00704225	0.264198108983441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.264198108983441
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00704225	0.264198108983441
PELGER-HUET ANOMALY; PHA	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.25696011811884867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.25696011811884867
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.25696011811884867
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.25696011811884867
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00684932	0.25696011811884867
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00684932	0.25696011811884867
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00684932	0.25696011811884867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00684932	0.25696011811884867
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00684932	0.25696011811884867
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.25696011811884867
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00684932	0.25696011811884867
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00684932	0.25696011811884867
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00684932	0.25696011811884867
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.25696011811884867
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.25696011811884867
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.25696011811884867
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00684932	0.25696011811884867
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00684932	0.25696011811884867
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00666667	0.25010779327865906
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.25010779327865906
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	0.25010779327865906
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00666667	0.25010779327865906
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.25010779327865906
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00666667	0.25010779327865906
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.25010779327865906
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.25010779327865906
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00666667	0.25010779327865906
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.25010779327865906
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.25010779327865906
CLASSIC GALACTOSEMIA	0.00666667	0.25010779327865906
COSTELLO SYNDROME; CSTLO	0.00666667	0.25010779327865906
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.25010779327865906
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.00666667	0.25010779327865906
PROPIONIC ACIDEMIA	0.00666667	0.25010779327865906
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	0.25010779327865906
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.25010779327865906
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	0.25010779327865906
LARON SYNDROME	0.00666667	0.25010779327865906
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.25010779327865906
NEONATAL HEMOCHROMATOSIS	0.00666667	0.25010779327865906
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00666667	0.25010779327865906
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.25010779327865906
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	0.25010779327865906
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00666667	0.25010779327865906
PANHYPOPITUITARISM	0.00666667	0.25010779327865906
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00666667	0.25010779327865906
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00666667	0.25010779327865906
MPI-CDG	0.00666667	0.25010779327865906
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	0.25010779327865906
LEPRECHAUNISM	0.00666667	0.25010779327865906
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.25010779327865906
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.25010779327865906
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.25010779327865906
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00666667	0.25010779327865906
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	0.25010779327865906
PARIETAL FORAMINA	0.005917759	0.22201153569097073
OPTIC PATHWAY GLIOMA	0.005917759	0.22201153569097073
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005917759	0.22201153569097073
GLIOBLASTOMA	0.005917759	0.22201153569097073
LHERMITTE-DUCLOS DISEASE	0.005917759	0.22201153569097073
ADIPOSIS DOLOROSA	0.005917759	0.22201153569097073
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.005917759	0.22201153569097073
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.005917759	0.22201153569097073
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005917759	0.22201153569097073
CRANIOPHARYNGIOMA	0.005917759	0.22201153569097073
WYBURN-MASON SYNDROME	0.005917759	0.22201153569097073
NON-FUNCTIONING PITUITARY ADENOMA	0.005917759	0.22201153569097073
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.005917759	0.22201153569097073
L1 SYNDROME	0.005917759	0.22201153569097073
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.005917759	0.22201153569097073
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.005917759	0.22201153569097073
PROLACTINOMA	0.005917759	0.22201153569097073
NEUROFIBROMATOSIS TYPE 1	0.005917759	0.22201153569097073
NARP SYNDROME	0.005917759	0.22201153569097073
PINEOBLASTOMA	0.005917759	0.22201153569097073
CRANIOSYNOSTOSIS 2	0.005917759	0.22201153569097073
15Q OVERGROWTH SYNDROME	0.005917759	0.22201153569097073
TSH-SECRETING PITUITARY ADENOMA	0.005917759	0.22201153569097073
FAMILIAL THROMBOCYTOSIS	0.005917759	0.22201153569097073
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.005917759	0.22201153569097073
NEUROFIBROMATOSIS, TYPE II	0.005917759	0.22201153569097073
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.005917759	0.22201153569097073
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.005917759	0.22201153569097073
PAPILLOMA OF CHOROID PLEXUS	0.005917759	0.22201153569097073
EBOLA HEMORRHAGIC FEVER	0.005917759	0.22201153569097073
HEMANGIOBLASTOMA	0.00537634	0.20169957914757827
CAMURATI-ENGELMANN DISEASE	0.00537634	0.20169957914757827
CENTRAL NEUROCYTOMA	0.00537634	0.20169957914757827
THYMIC TUMOR	0.00537634	0.20169957914757827
PARKES WEBER SYNDROME	0.00537634	0.20169957914757827
SOLAR URTICARIA	0.00537634	0.20169957914757827
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.20169957914757827
PINEOCYTOMA	0.00537634	0.20169957914757827
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.20169957914757827
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.20169957914757827
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.20169957914757827
INTERNAL CAROTID AGENESIS	0.00537634	0.20169957914757827
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.20169957914757827
PITUICYTOMA	0.00537634	0.20169957914757827
PITUITARY CARCINOMA	0.00537634	0.20169957914757827
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.20169957914757827
PANHYPOPHYSITIS	0.00537634	0.20169957914757827
SCLEROSTEOSIS 1; SOST1	0.00537634	0.20169957914757827
ADENOHYPOPHYSITIS	0.00537634	0.20169957914757827
ACROOSTEOLYSIS DOMINANT TYPE	0.00537634	0.20169957914757827
CARNEY TRIAD	0.00537634	0.20169957914757827
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.20169957914757827
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.20169957914757827
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.20169957914757827
PERINEURAL CYST	0.00537634	0.20169957914757827
BRUNNER SYNDROME; BRNRS	0.00537634	0.20169957914757827
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.20169957914757827
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.20169957914757827
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.20169957914757827
CUSHING DISEASE	0.00537634	0.20169957914757827
EPISODIC ATAXIA, TYPE 3	0.00537634	0.20169957914757827
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00537634	0.20169957914757827
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.20169957914757827
CUTANEOUS MASTOCYTOSIS	0.00537634	0.20169957914757827
PRIMARY PARATHYROID HYPERPLASIA	0.00537634	0.20169957914757827
IDIOPATHIC PANUVEITIS	0.00537634	0.20169957914757827
HYPER-IGD SYNDROME	0.00537634	0.20169957914757827
CROUZON DISEASE	0.00537634	0.20169957914757827
TEMPI SYNDROME	0.00537634	0.20169957914757827
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.20169957914757827
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.20169957914757827
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.20169957914757827
CUTANEOUS MASTOCYTOMA	0.00537634	0.20169957914757827
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.20169957914757827
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.20169957914757827
SEVERE HEMOPHILIA A	0.00537634	0.20169957914757827
CHIARI MALFORMATION TYPE I	0.00537634	0.20169957914757827
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.20169957914757827
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.20169957914757827
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00537634	0.20169957914757827
MANGANESE POISONING	0.00537634	0.20169957914757827
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.20169957914757827
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.20169957914757827
COLD AGGLUTININ DISEASE	0.00537634	0.20169957914757827
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.20169957914757827
SYSTEMIC MASTOCYTOSIS	0.00537634	0.20169957914757827
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.20169957914757827
PARATHYROID CARCINOMA	0.00537634	0.20169957914757827
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.20169957914757827
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.20169957914757827
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00537634	0.20169957914757827
SUSAC SYNDROME	0.00537634	0.20169957914757827
ALPORT SYNDROME	0.00537634	0.20169957914757827
EPISODIC ATAXIA TYPE 1	0.00537634	0.20169957914757827
PRIMARY CILIARY DYSKINESIA	0.00537634	0.20169957914757827
SYDENHAM CHOREA	0.00537634	0.20169957914757827
CONGENITAL TOXOPLASMOSIS	0.0044629890000000005	0.1674341658154565
17Q12 MICRODELETION SYNDROME	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0044629890000000005	0.1674341658154565
SIALURIA	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0044629890000000005	0.1674341658154565
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0044629890000000005	0.1674341658154565
CHOREOACANTHOCYTOSIS	0.0044629890000000005	0.1674341658154565
OROFACIODIGITAL SYNDROME TYPE 1	0.0044629890000000005	0.1674341658154565
SRD5A3-CDG	0.0044629890000000005	0.1674341658154565
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0044629890000000005	0.1674341658154565
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0044629890000000005	0.1674341658154565
RETINITIS PIGMENTOSA 59; RP59	0.0044629890000000005	0.1674341658154565
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0044629890000000005	0.1674341658154565
ATAXIA-TELANGIECTASIA	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0044629890000000005	0.1674341658154565
IMMUNODEFICIENCY 47	0.0044629890000000005	0.1674341658154565
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0044629890000000005	0.1674341658154565
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0044629890000000005	0.1674341658154565
COG5-CDG	0.0044629890000000005	0.1674341658154565
PREECLAMPSIA/ECLAMPSIA 1	0.0044629890000000005	0.1674341658154565
ALG11-CDG	0.0044629890000000005	0.1674341658154565
ISOLATED BILIARY ATRESIA	0.0044629890000000005	0.1674341658154565
CLASSIC HOMOCYSTINURIA	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.0044629890000000005	0.1674341658154565
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0044629890000000005	0.1674341658154565
DDOST-CDG	0.0044629890000000005	0.1674341658154565
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0044629890000000005	0.1674341658154565
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0044629890000000005	0.1674341658154565
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0044629890000000005	0.1674341658154565
COACH SYNDROME	0.0044629890000000005	0.1674341658154565
LATHOSTEROLOSIS	0.0044629890000000005	0.1674341658154565
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004329299	0.16241863169070994
ASPARTYLGLUCOSAMINURIA; AGU	0.004329299	0.16241863169070994
GAPO SYNDROME; GAPOS	0.004329299	0.16241863169070994
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004329299	0.16241863169070994
CHROMOSOME 10Q26 DELETION SYNDROME	0.004329299	0.16241863169070994
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16241863169070994
SALLA DISEASE	0.004329299	0.16241863169070994
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070994
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004329299	0.16241863169070994
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16241863169070994
EMANUEL SYNDROME	0.004329299	0.16241863169070994
XYLOSIDASE DEFICIENCY	0.004329299	0.16241863169070994
EPILEPSY-TELANGIECTASIA	0.004329299	0.16241863169070994
NEURONAL CEROID LIPOFUSCINOSIS	0.004329299	0.16241863169070994
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004329299	0.16241863169070994
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004329299	0.16241863169070994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004329299	0.16241863169070994
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004329299	0.16241863169070994
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070994
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.004329299	0.16241863169070994
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004329299	0.16241863169070994
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004329299	0.16241863169070994
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16241863169070994
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004329299	0.16241863169070994
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004329299	0.16241863169070994
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004329299	0.16241863169070994
FABRY DISEASE	0.004272759	0.1602974685564952
PORPHYRIA	0.004272759	0.1602974685564952
FAMILIAL MEDITERRANEAN FEVER	0.004272759	0.1602974685564952
HYPOPHOSPHATASIA, INFANTILE	0.004272759	0.1602974685564952
CHÉDIAK-HIGASHI SYNDROME	0.004272759	0.1602974685564952
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004272759	0.1602974685564952
NEPHROGENIC DIABETES INSIPIDUS	0.004272759	0.1602974685564952
WHIPPLE DISEASE	0.004272759	0.1602974685564952
MIXED CONNECTIVE TISSUE DISEASE	0.004272759	0.1602974685564952
XERODERMA PIGMENTOSUM	0.004272759	0.1602974685564952
GRISCELLI SYNDROME TYPE 2	0.004272759	0.1602974685564952
MICROSPORIDIOSIS	0.004272759	0.1602974685564952
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.004272759	0.1602974685564952
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004272759	0.1602974685564952
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.004272759	0.1602974685564952
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004272759	0.1602974685564952
GRISCELLI SYNDROME	0.004272759	0.1602974685564952
LYMPHANGIOLEIOMYOMATOSIS	0.004272759	0.1602974685564952
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.004272759	0.1602974685564952
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004272759	0.1602974685564952
CHRONIC GRAFT VERSUS HOST DISEASE	0.00392157	0.147122209272064
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00392157	0.147122209272064
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00392157	0.147122209272064
JEJUNAL NEUROENDOCRINE TUMOR	0.00392157	0.147122209272064
HEMOCHROMATOSIS, TYPE 1	0.00392157	0.147122209272064
ILEAL NEUROENDOCRINE TUMOR	0.00392157	0.147122209272064
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00392157	0.147122209272064
DUODENAL NEUROENDOCRINE TUMOR	0.00392157	0.147122209272064
CHYLOMICRON RETENTION DISEASE	0.00392157	0.147122209272064
NEUROENDOCRINE TUMOR OF THE COLON	0.00392157	0.147122209272064
TURNER SYNDROME	0.00392157	0.147122209272064
MONOSOMY X	0.00392157	0.147122209272064
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00392157	0.147122209272064
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00392157	0.147122209272064
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00392157	0.147122209272064
MOSAIC MONOSOMY X	0.00392157	0.147122209272064
DPM3-CDG	0.00392157	0.147122209272064
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00392157	0.147122209272064
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.00392157	0.147122209272064
CARCINOID SYNDROME	0.00392157	0.147122209272064
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00392157	0.147122209272064
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00392157	0.147122209272064
NEUROENDOCRINE TUMOR OF STOMACH	0.00392157	0.147122209272064
HEMOCHROMATOSIS, TYPE 3; HFE3	0.00392157	0.147122209272064
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00392157	0.147122209272064
LYSINURIC PROTEIN INTOLERANCE	0.00392157	0.147122209272064
BECKER MUSCULAR DYSTROPHY	0.00392157	0.147122209272064
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00392157	0.147122209272064
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00392157	0.147122209272064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.00392157	0.147122209272064
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.00392157	0.147122209272064
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00392157	0.147122209272064
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00392157	0.147122209272064
DK1-CDG	0.00392157	0.147122209272064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.147122209272064
HARDIKAR SYNDROME	0.00392157	0.147122209272064
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.147122209272064
NEONATAL LUPUS ERYTHEMATOSUS	0.00392157	0.147122209272064
GRAFT VERSUS HOST DISEASE	0.00392157	0.147122209272064
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.00392157	0.147122209272064
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00392157	0.147122209272064
HEMOCHROMATOSIS, TYPE 2B	0.00392157	0.147122209272064
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00392157	0.147122209272064
TOXIC EPIDERMAL NECROLYSIS	0.00392157	0.147122209272064
REYNOLDS SYNDROME	0.00392157	0.147122209272064
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.00392157	0.147122209272064
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00392157	0.147122209272064
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.00392157	0.147122209272064
RETINITIS PIGMENTOSA 71; RP71	0.00392157	0.147122209272064
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00392157	0.147122209272064
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00392157	0.147122209272064
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.00392157	0.147122209272064
ALSTROM SYNDROME; ALMS	0.00392157	0.147122209272064
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.147122209272064
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.147122209272064
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00392157	0.147122209272064
HEMOCHROMATOSIS TYPE 2	0.00392157	0.147122209272064
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00392157	0.147122209272064
PEDIATRIC-ONSET GRAVES DISEASE	0.00392157	0.147122209272064
SCLEROSING CHOLANGITIS, NEONATAL	0.00392157	0.147122209272064
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00392157	0.147122209272064
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00392157	0.147122209272064
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.147122209272064
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00392157	0.147122209272064
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00392157	0.147122209272064
AUTOIMMUNE HEPATITIS	0.00392157	0.147122209272064
BARDET-BIEDL SYNDROME 21; BBS21	0.00392157	0.147122209272064
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00392157	0.147122209272064
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.00392157	0.147122209272064
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.00392157	0.147122209272064
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00392157	0.147122209272064
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.00392157	0.147122209272064
NEUTRAL LIPID STORAGE MYOPATHY	0.00392157	0.147122209272064
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00392157	0.147122209272064
MYH9-RELATED DISEASE	0.00392157	0.147122209272064
DISORDER OF BILE ACID SYNTHESIS	0.00392157	0.147122209272064
MEVALONIC ACIDURIA; MEVA	0.00392157	0.147122209272064
COMMON VARIABLE IMMUNODEFICIENCY	0.00392157	0.147122209272064
FAMILIAL PANCREATIC CARCINOMA	0.00392157	0.147122209272064
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00392157	0.147122209272064
XFE PROGEROID SYNDROME; XFEPS	0.00392157	0.147122209272064
WILSON DISEASE	0.00392157	0.147122209272064
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00392157	0.147122209272064
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00392157	0.147122209272064
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731745
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731745
46,XX GONADAL DYSGENESIS	0.00378788	0.14210667514731745
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731745
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731745
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731745
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731745
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731745
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731745
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731745
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.14210667514731745
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731745
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731745
REFSUM DISEASE	0.00378788	0.14210667514731745
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731745
REVESZ SYNDROME	0.00378788	0.14210667514731745
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.14210667514731745
BEETURIA	0.00378788	0.14210667514731745
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731745
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731745
PYGMY	0.00378788	0.14210667514731745
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.14210667514731745
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.14210667514731745
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731745
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731745
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731745
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.14210667514731745
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731745
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.14210667514731745
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731745
PITUITARY DWARFISM IV	0.00378788	0.14210667514731745
LARON SYNDROME	0.00378788	0.14210667514731745
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731745
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731745
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731745
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731745
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731745
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731745
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731745
CARBOXYLESTERASE 1	0.00378788	0.14210667514731745
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731745
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731745
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.14210667514731745
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731745
COUMARIN RESISTANCE	0.00378788	0.14210667514731745
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731745
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731745
BARTTER SYNDROME	0.00378788	0.14210667514731745
XANTHINURIA, TYPE I	0.00378788	0.14210667514731745
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.14210667514731745
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731745
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731745
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.14210667514731745
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731745
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731745
PENDRED SYNDROME	0.00378788	0.14210667514731745
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731745
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.14210667514731745
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.14210667514731745
CUTIS LAXA	0.00378788	0.14210667514731745
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.14210667514731745
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.14210667514731745
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731745
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731745
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731745
NEPHROSIALIDOSIS	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731745
TRISOMY 18-LIKE SYNDROME	0.00378788	0.14210667514731745
LARSEN-LIKE SYNDROME	0.00378788	0.14210667514731745
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731745
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731745
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.14210667514731745
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731745
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731745
SPINAL ARACHNOIDITIS	0.00378788	0.14210667514731745
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731745
AREDYLD	0.00378788	0.14210667514731745
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731745
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731745
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
OSTEOMESOPYKNOSIS	0.00378788	0.14210667514731745
GLUTATHIONURIA	0.00378788	0.14210667514731745
ETHANOLAMINOSIS	0.00378788	0.14210667514731745
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731745
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.14210667514731745
HOOFT DISEASE	0.00378788	0.14210667514731745
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.14210667514731745
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731745
DERMATITIS, ATOPIC	0.00378788	0.14210667514731745
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731745
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731745
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731745
CEPHALIN LIPIDOSIS	0.00378788	0.14210667514731745
HYPOASCORBEMIA	0.00378788	0.14210667514731745
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731745
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.14210667514731745
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731745
OVARIAN CANCER	0.00378788	0.14210667514731745
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.14210667514731745
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731745
PARAOXONASE 1	0.00378788	0.14210667514731745
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731745
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731745
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731745
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.14210667514731745
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731745
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.14210667514731745
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731745
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.14210667514731745
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731745
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731745
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.14210667514731745
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731745
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.14210667514731745
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.14210667514731745
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731745
PACMAN DYSPLASIA	0.00378788	0.14210667514731745
PERRY SYNDROME	0.00378788	0.14210667514731745
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731745
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.14210667514731745
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731745
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731745
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731745
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.14210667514731745
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731745
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.14210667514731745
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731745
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.14210667514731745
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731745
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.14210667514731745
ACETYLATION, SLOW	0.00378788	0.14210667514731745
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.14210667514731745
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731745
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.14210667514731745
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731745
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731745
GLOMUVENOUS MALFORMATIONS	0.00378788	0.14210667514731745
ONCOCYTOMA	0.00378788	0.14210667514731745
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731745
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.14210667514731745
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731745
GONADOBLASTOMA	0.00378788	0.14210667514731745
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731745
XM SYSTEM	0.00378788	0.14210667514731745
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731745
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.14210667514731745
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731745
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731745
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731745
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731745
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731745
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731745
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731745
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731745
ICHTHYOSIS, X-LINKED	0.00378788	0.14210667514731745
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731745
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731745
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.14210667514731745
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731745
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731745
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731745
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731745
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731745
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731745
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.14210667514731745
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731745
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731745
ALKAPTONURIA	0.00378788	0.14210667514731745
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.14210667514731745
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731745
SCHIZOPHRENIA 4	0.00378788	0.14210667514731745
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731745
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.14210667514731745
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731745
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731745
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731745
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731745
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731745
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.14210667514731745
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731745
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731745
KUFOR-RAKEB SYNDROME	0.00373134	0.13998551201310272
POLYEMBRYOMA	0.00373134	0.13998551201310272
TETANUS	0.00373134	0.13998551201310272
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.13998551201310272
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00373134	0.13998551201310272
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00373134	0.13998551201310272
OMENN SYNDROME	0.00373134	0.13998551201310272
ERDHEIM-CHESTER DISEASE	0.00373134	0.13998551201310272
RETICULAR DYSGENESIS	0.00373134	0.13998551201310272
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00373134	0.13998551201310272
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00373134	0.13998551201310272
MELIOIDOSIS	0.00373134	0.13998551201310272
ROTOR SYNDROME	0.00373134	0.13998551201310272
JUVENILE DERMATOMYOSITIS	0.00373134	0.13998551201310272
WOUND BOTULISM	0.00373134	0.13998551201310272
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.00373134	0.13998551201310272
CONGENITAL FIBRINOGEN DEFICIENCY	0.00373134	0.13998551201310272
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.00373134	0.13998551201310272
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310272
SEVERE COMBINED IMMUNODEFICIENCY	0.00373134	0.13998551201310272
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.00373134	0.13998551201310272
SCHNITZLER SYNDROME	0.00373134	0.13998551201310272
TUBERCULOSIS	0.00373134	0.13998551201310272
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.00373134	0.13998551201310272
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.00373134	0.13998551201310272
JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.13998551201310272
CHRONIC GRANULOMATOUS DISEASE	0.00373134	0.13998551201310272
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00373134	0.13998551201310272
SARCOIDOSIS	0.00373134	0.13998551201310272
REYNOLDS SYNDROME	0.00373134	0.13998551201310272
MALT LYMPHOMA	0.00373134	0.13998551201310272
MICROSCOPIC POLYANGIITIS	0.00373134	0.13998551201310272
ACUTE MONOBLASTIC LEUKEMIA	0.00373134	0.13998551201310272
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.00373134	0.13998551201310272
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00373134	0.13998551201310272
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00373134	0.13998551201310272
ACUTE PROMYELOCYTIC LEUKEMIA	0.00373134	0.13998551201310272
CHRONIC MYELOID LEUKEMIA	0.00373134	0.13998551201310272
MANTLE CELL LYMPHOMA	0.00373134	0.13998551201310272
CHOLANGIOCARCINOMA	0.00373134	0.13998551201310272
DUBIN-JOHNSON SYNDROME	0.00373134	0.13998551201310272
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00373134	0.13998551201310272
OSTEOSARCOMA	0.00373134	0.13998551201310272
NEPHROBLASTOMA	0.00373134	0.13998551201310272
CRYOGLOBULINEMIC VASCULITIS	0.00373134	0.13998551201310272
PULMONARY BLASTOMA	0.00373134	0.13998551201310272
HEREDITARY SPHEROCYTOSIS	0.00373134	0.13998551201310272
FOLLICULAR LYMPHOMA	0.00373134	0.13998551201310272
ANTISYNTHETASE SYNDROME	0.00373134	0.13998551201310272
MALAKOPLAKIA	0.00373134	0.13998551201310272
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.00373134	0.13998551201310272
MUCKLE-WELLS SYNDROME	0.00373134	0.13998551201310272
CONGENITAL PRIMARY MEGAURETER	0.00373134	0.13998551201310272
MACROPHAGIC MYOFASCIITIS	0.00373134	0.13998551201310272
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00373134	0.13998551201310272
MELKERSSON-ROSENTHAL SYNDROME	0.00373134	0.13998551201310272
FAMILIAL ATRIAL MYXOMA	0.00373134	0.13998551201310272
POLYMYOSITIS	0.00373134	0.13998551201310272
ISOLATED AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310272
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.13998551201310272
ADULT IDIOPATHIC NEUTROPENIA	0.00373134	0.13998551201310272
REACTIVE ARTHRITIS	0.00373134	0.13998551201310272
CONGENITAL ENTEROVIRUS INFECTION	0.00373134	0.13998551201310272
WISKOTT-ALDRICH SYNDROME	0.00373134	0.13998551201310272
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.00373134	0.13998551201310272
WELLS SYNDROME	0.00373134	0.13998551201310272
HEREDITARY ELLIPTOCYTOSIS	0.00373134	0.13998551201310272
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00373134	0.13998551201310272
POLYARTERITIS NODOSA	0.00373134	0.13998551201310272
CYSTINOSIS	0.00373134	0.13998551201310272
PYOMYOSITIS	0.00373134	0.13998551201310272
IDIOPATHIC BRONCHIECTASIS	0.00373134	0.13998551201310272
KAPOSIFORM LYMPHANGIOMATOSIS	0.00373134	0.13998551201310272
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.00373134	0.13998551201310272
WOLMAN DISEASE	0.00373134	0.13998551201310272
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00373134	0.13998551201310272
DERMATOMYOSITIS	0.00373134	0.13998551201310272
X-LINKED AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310272
CUTANEOUS SMALL VESSEL VASCULITIS	0.00373134	0.13998551201310272
PYODERMA GANGRENOSUM	0.00373134	0.13998551201310272
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.00373134	0.13998551201310272
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00373134	0.13998551201310272
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00373134	0.13998551201310272
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.00373134	0.13998551201310272
FOCAL MYOSITIS	0.00373134	0.13998551201310272
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00373134	0.13998551201310272
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00373134	0.13998551201310272
KLATSKIN TUMOR	0.00373134	0.13998551201310272
GLYCOGEN STORAGE DISEASE II	0.00373134	0.13998551201310272
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.00373134	0.13998551201310272
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00373134	0.13998551201310272
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00373134	0.13998551201310272
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00373134	0.13998551201310272
CAFFEY DISEASE	0.00373134	0.13998551201310272
STIFF-PERSON SYNDROME; SPS	0.00373134	0.13998551201310272
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00373134	0.13998551201310272
RAGWEED SENSITIVITY	0.00373134	0.13998551201310272
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00373134	0.13998551201310272
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.00373134	0.13998551201310272
PANCREATITIS, HEREDITARY	0.00373134	0.13998551201310272
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00373134	0.13998551201310272
NEUROPATHY, PAINFUL	0.00373134	0.13998551201310272
CYCLIC NEUTROPENIA	0.00373134	0.13998551201310272
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.13998551201310272
PSORIASIS 14, PUSTULAR	0.00373134	0.13998551201310272
PSEUDODIASTROPHIC DYSPLASIA	0.00373134	0.13998551201310272
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00373134	0.13998551201310272
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00373134	0.13998551201310272
CIRRHOSIS, FAMILIAL	0.00373134	0.13998551201310272
AREGENERATIVE ANEMIA	0.00373134	0.13998551201310272
HALOTHANE HEPATITIS	0.00373134	0.13998551201310272
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.00373134	0.13998551201310272
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00373134	0.13998551201310272
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00373134	0.13998551201310272
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00373134	0.13998551201310272
FEVER, FAMILIAL LIFELONG PERSISTENT	0.00373134	0.13998551201310272
IMMUNODEFICIENCY 32B; IMD32B	0.00373134	0.13998551201310272
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.00373134	0.13998551201310272
MU-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310272
ALPHA-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310272
GAMMA-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310272
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00373134	0.13998551201310272
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00373134	0.13998551201310272
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.00373134	0.13998551201310272
CINCA SYNDROME; CINCA	0.00373134	0.13998551201310272
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00373134	0.13998551201310272
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.00373134	0.13998551201310272
DYSTONIA 12; DYT12	0.00373134	0.13998551201310272
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00373134	0.13998551201310272
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00373134	0.13998551201310272
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.00373134	0.13998551201310272
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00373134	0.13998551201310272
CAFFEY DISEASE	0.00373134	0.13998551201310272
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.020311956543392472
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000541419	0.020311956543392472
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020311956543392472
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.000541419	0.020311956543392472
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.020311956543392472
WIEACKER-WOLFF SYNDROME	0.000541419	0.020311956543392472
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392472
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.020311956543392472
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000541419	0.020311956543392472
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392472
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020311956543392472
BAND HETEROTOPIA; BH	0.000541419	0.020311956543392472
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020311956543392472
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392472
WAISMAN SYNDROME; WSMN	0.000541419	0.020311956543392472
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.020311956543392472
RETT SYNDROME; RTT	0.000541419	0.020311956543392472
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392472
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020311956543392472
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020311956543392472
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.020311956543392472
8Q24.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.020311956543392472
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.020311956543392472
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
MAPLE SYRUP URINE DISEASE	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020311956543392472
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392472
WHIM SYNDROME	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.020311956543392472
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392472
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
CODAS SYNDROME	0.000541419	0.020311956543392472
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392472
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392472
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000541419	0.020311956543392472
ALSTRÖM SYNDROME	0.000541419	0.020311956543392472
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
NETHERTON SYNDROME	0.000541419	0.020311956543392472
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000541419	0.020311956543392472
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.020311956543392472
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.020311956543392472
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020311956543392472
LEBER CONGENITAL AMAUROSIS	0.000541419	0.020311956543392472
XQ25 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.000541419	0.020311956543392472
MEND SYNDROME; MEND	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000541419	0.020311956543392472
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392472
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.020311956543392472
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392472
MYASTHENIA GRAVIS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392472
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
MENKES DISEASE	0.000541419	0.020311956543392472
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392472
22Q11.2 DELETION SYNDROME	0.000541419	0.020311956543392472
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392472
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392472
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.020311956543392472
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392472
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
HHHH SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000541419	0.020311956543392472
PETTIGREW SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392472
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392472
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392472
LEIGH SYNDROME	0.000541419	0.020311956543392472
POTOCKI-LUPSKI SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392472
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392472
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 3	0.000541419	0.020311956543392472
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020311956543392472
HOLOPROSENCEPHALY 7	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392472
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA	0.000541419	0.020311956543392472
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392472
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000541419	0.020311956543392472
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392472
PGM3-CDG	0.000541419	0.020311956543392472
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000541419	0.020311956543392472
SCHINDLER DISEASE, TYPE I	0.000541419	0.020311956543392472
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392472
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392472
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.020311956543392472
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000541419	0.020311956543392472
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392472
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020311956543392472
KOOLEN-DE VRIES SYNDROME; KDVS	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
PHACE SYNDROME	0.000541419	0.020311956543392472
GLASS SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020311956543392472
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392472
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.020311956543392472
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020311956543392472
ADNP SYNDROME	0.000541419	0.020311956543392472
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.020311956543392472
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392472
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392472
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020311956543392472
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020311956543392472
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.020311956543392472
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
TEMPLE-BARAITSER SYNDROME	0.000541419	0.020311956543392472
611961 STEVENSON-CAREY SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000541419	0.020311956543392472
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392472
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392472
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000541419	0.020311956543392472
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.020311956543392472
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.000541419	0.020311956543392472
BOHRING-OPITZ SYNDROME	0.000541419	0.020311956543392472
MONOSOMY 22Q13.3	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000541419	0.020311956543392472
PHELAN-MCDERMID SYNDROME	0.000541419	0.020311956543392472
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392472
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.020311956543392472
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
9Q33.3Q34.11 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392472
MUENKE SYNDROME	0.000541419	0.020311956543392472
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.020311956543392472
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000541419	0.020311956543392472
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392472
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000541419	0.020311956543392472
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020311956543392472
16P13.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
PIERPONT SYNDROME	0.000541419	0.020311956543392472
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020311956543392472
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392472
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.020311956543392472
KALLMANN SYNDROME	0.000541419	0.020311956543392472
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000541419	0.020311956543392472
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.020311956543392472
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.020311956543392472
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
INCONTINENTIA PIGMENTI	0.000541419	0.020311956543392472
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392472
LATHOSTEROLOSIS	0.000541419	0.020311956543392472
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392472
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.020311956543392472
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.020311956543392472
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392472
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020311956543392472
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
JOUBERT SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY 1; LIS1	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.020311956543392472
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392472
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.020311956543392472
KAGAMI-OGATA SYNDROME	0.000541419	0.020311956543392472
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392472
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.020311956543392472
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020311956543392472
AUTISM	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392472
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392472
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392472
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020311956543392472
BANGSTAD SYNDROME	0.000541419	0.020311956543392472
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392472
C SYNDROME	0.000541419	0.020311956543392472
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392472
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392472
ZELLWEGER SYNDROME	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392472
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392472
DIGEORGE SYNDROME; DGS	0.000541419	0.020311956543392472
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020311956543392472
PARTINGTON SYNDROME	0.000541419	0.020311956543392472
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
15Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392472
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392472
FG SYNDROME TYPE 1	0.000541419	0.020311956543392472
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020311956543392472
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392472
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392472
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.020311956543392472
DIAMINOPENTANURIA	0.000541419	0.020311956543392472
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392472
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392472
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392472
FOLATE MALABSORPTION, HEREDITARY	0.000541419	0.020311956543392472
ARGININEMIA	0.000541419	0.020311956543392472
WALKER-WARBURG SYNDROME	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE II	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392472
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392472
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
HARTNUP DISORDER	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020311956543392472
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392472
FRAGILE X SYNDROME	0.000541419	0.020311956543392472
COCKAYNE SYNDROME A; CSA	0.000541419	0.020311956543392472
COHEN SYNDROME	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.020311956543392472
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392472
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392472
CROME SYNDROME	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.020311956543392472
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
SMITH-MAGENIS SYNDROME; SMS	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392472
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020311956543392472
CROUZON SYNDROME	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392472
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392472
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 1; CSS1	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
MYHRE SYNDROME	0.000541419	0.020311956543392472
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392472
HADDAD SYNDROME	0.000541419	0.020311956543392472
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.000541419	0.020311956543392472
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392472
XQ28 (MECP2) DUPLICATION	0.000541419	0.020311956543392472
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392472
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.020311956543392472
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME	0.000541419	0.020311956543392472
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392472
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.020311956543392472
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392472
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
EMANUEL SYNDROME	0.000541419	0.020311956543392472
KOOLEN-DE VRIES SYNDROME	0.000541419	0.020311956543392472
RECOMBINANT 8 SYNDROME	0.000541419	0.020311956543392472
NON-DISTAL MONOSOMY 20Q	0.000541419	0.020311956543392472
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020311956543392472
DISTAL MONOSOMY 10Q	0.000541419	0.020311956543392472
DISTAL MONOSOMY 19P13.3	0.000541419	0.020311956543392472
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020311956543392472
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
PRADER-WILLI SYNDROME; PWS	0.000541419	0.020311956543392472
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.020311956543392472
48,XXXY SYNDROME	0.000541419	0.020311956543392472
49,XXXXY SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
PALLISTER-HALL SYNDROME	0.000541419	0.020311956543392472
KABUKI SYNDROME 1	0.000541419	0.020311956543392472
KBG SYNDROME	0.000541419	0.020311956543392472
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392472
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME	0.000541419	0.020311956543392472
BOHRING-OPITZ SYNDROME	0.000541419	0.020311956543392472
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020311956543392472
HOLOPROSENCEPHALY 2; HPE2	0.000541419	0.020311956543392472
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392472
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020311956543392472
SIALIDOSIS TYPE 2	0.000541419	0.020311956543392472
MOWAT-WILSON SYNDROME; MOWS	0.000541419	0.020311956543392472
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020311956543392472
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392472
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392472
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.020311956543392472
CLASSIC PHENYLKETONURIA	0.000541419	0.020311956543392472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392472
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000541419	0.020311956543392472
PETERS-PLUS SYNDROME; PTRPLS	0.000541419	0.020311956543392472
PHENYLKETONURIA	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392472
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392472
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392472
MOGS-CDG	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
ALG1-CDG	0.000541419	0.020311956543392472
ALG2-CDG	0.000541419	0.020311956543392472
MPDU1-CDG	0.000541419	0.020311956543392472
DPM1-CDG	0.000541419	0.020311956543392472
ALG3-CDG	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392472
ELEJALDE DISEASE	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392472
DEND SYNDROME	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392472
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392472
WEAVER SYNDROME	0.000541419	0.020311956543392472
6Q TERMINAL DELETION SYNDROME	0.000541419	0.020311956543392472
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392472
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
PROTEUS SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392472
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392472
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
INFANTILE SIALIC ACID STORAGE DISEASE	0.000541419	0.020311956543392472
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392472
RUBINSTEIN-TAYBI SYNDROME	0.000541419	0.020311956543392472
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392472
RETT SYNDROME	0.000541419	0.020311956543392472
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392472
MONOSOMY 9Q22.3	0.000541419	0.020311956543392472
INFANTILE REFSUM DISEASE	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.000541419	0.020311956543392472
SULFOCYSTEINURIA	0.000541419	0.020311956543392472
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392472
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392472
TRIPLE A SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392472
MEHMO SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020311956543392472
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392472
KEUTEL SYNDROME	0.000541419	0.020311956543392472
GENITOPATELLAR SYNDROME	0.000541419	0.020311956543392472
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
KAPUR-TORIELLO SYNDROME	0.000541419	0.020311956543392472
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
TAY-SACHS DISEASE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000541419	0.020311956543392472
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392472
DPAGT1-CDG	0.000541419	0.020311956543392472
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392472
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392472
KETOADIPICACIDURIA	0.000541419	0.020311956543392472
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
SCLERODERMA	0.000541419	0.020311956543392472
47,XYY SYNDROME	0.000541419	0.020311956543392472
SCHIZENCEPHALY	0.000541419	0.020311956543392472
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
SANDHOFF DISEASE	0.000541419	0.020311956543392472
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 1	0.000541419	0.020311956543392472
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392472
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.020311956543392472
OHDO SYNDROME	0.000541419	0.020311956543392472
SIALIDOSIS TYPE 1	0.000541419	0.020311956543392472
MARDEN-WALKER SYNDROME	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
CAMOS SYNDROME	0.000541419	0.020311956543392472
FREE SIALIC ACID STORAGE DISEASE	0.000541419	0.020311956543392472
MACDERMOT-WINTER SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.020311956543392472
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392472
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392472
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392472
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392472
SMITH-MAGENIS SYNDROME	0.000541419	0.020311956543392472
SMITH-LEMLI-OPITZ SYNDROME	0.000541419	0.020311956543392472
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020311956543392472
MEND SYNDROME	0.000541419	0.020311956543392472
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392472
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392472
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020311956543392472
8P23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
8P11.2 DELETION SYNDROME	0.000541419	0.020311956543392472
6Q25 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
2Q31.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392472
MICRO SYNDROME	0.000541419	0.020311956543392472
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.020311956543392472
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
AICA-RIBOSIDURIA	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000541419	0.020311956543392472
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.020311956543392472
CK SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.020311956543392472
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
19P13.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.000541419	0.020311956543392472
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000541419	0.020311956543392472
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.020311956543392472
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392472
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.020311956543392472
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392472
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392472
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000541419	0.020311956543392472
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000541419	0.020311956543392472
DUBOWITZ SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
KBG SYNDROME	0.000541419	0.020311956543392472
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392472
DUANE RETRACTION SYNDROME	0.000541419	0.020311956543392472
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392472
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392472
KABUKI SYNDROME	0.000541419	0.020311956543392472
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392472
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.020311956543392472
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.020311956543392472
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.020311956543392472
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020311956543392472
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392472
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392472
RFT1-CDG	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000541419	0.020311956543392472
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000541419	0.020311956543392472
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020311956543392472
KAGAMI-OGATA SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020311956543392472
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.020311956543392472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.020311956543392472
TRISOMY 8P	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.020311956543392472
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.020311956543392472
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.020311956543392472
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000541419	0.020311956543392472
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000541419	0.020311956543392472
OROFACIODIGITAL SYNDROME TYPE 6	0.000541419	0.020311956543392472
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020311956543392472
AL KAISSI SYNDROME; ALKAS	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000541419	0.020311956543392472
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392472
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000541419	0.020311956543392472
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.020311956543392472
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.020311956543392472
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392472
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392472
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392472
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.020311956543392472
MOYNAHAN SYNDROME	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
MOMO SYNDROME	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392472
MONOSOMY 9P	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020311956543392472
14Q12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392472
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392472
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.020311956543392472
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392472
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
15Q14 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000541419	0.020311956543392472
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000541419	0.020311956543392472
COHEN SYNDROME	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
CANAVAN DISEASE	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
XQ21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392472
COFFIN-LOWRY SYNDROME	0.000541419	0.020311956543392472
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392472
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392472
COCKAYNE SYNDROME	0.000541419	0.020311956543392472
RING CHROMOSOME 22 SYNDROME	0.000541419	0.020311956543392472
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392472
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392472
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.020311956543392472
COWDEN SYNDROME	0.000541419	0.020311956543392472
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020311956543392472
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392472
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
EAST SYNDROME	0.000541419	0.020311956543392472
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME	0.000541419	0.020311956543392472
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME	0.000541419	0.020311956543392472
COFS SYNDROME	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392472
DISTAL MONOSOMY 15Q	0.000541419	0.020311956543392472
MONOSOMY 18Q	0.000541419	0.020311956543392472
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392472
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000541419	0.020311956543392472
1P36 DELETION SYNDROME	0.000541419	0.020311956543392472
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
DISTAL MONOSOMY 3P	0.000541419	0.020311956543392472
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392472
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.020311956543392472
MOSAIC TRISOMY 14	0.000541419	0.020311956543392472
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392472
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392472
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSPLASIA	0.000541419	0.020311956543392472
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000541419	0.020311956543392472
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392472
CRISPONI SYNDROME	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392472
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392472
FAMILIAL DYSAUTONOMIA	0.000541419	0.020311956543392472
22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392472
KNOBLOCH SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000541419	0.020311956543392472
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392472
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392472
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392472
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
MATERNAL PHENYLKETONURIA	0.000541419	0.020311956543392472
JOUBERT SYNDROME WITH RENAL DEFECT	0.000541419	0.020311956543392472
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000541419	0.020311956543392472
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.020311956543392472
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392472
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392472
HYDRANENCEPHALY	0.000541419	0.020311956543392472
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020311956543392472
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392472
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000541419	0.020311956543392472
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.020311956543392472
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.020311956543392472
48,XXYY SYNDROME	0.000541419	0.020311956543392472
JACOBSEN SYNDROME	0.000541419	0.020311956543392472
2Q37 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392472
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
2Q23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392472
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
HALL-RIGGS SYNDROME	0.000541419	0.020311956543392472
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392472
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392472
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392472
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
C SYNDROME	0.000541419	0.020311956543392472
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME	0.000541419	0.020311956543392472
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392472
FRYNS SYNDROME	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392472
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392472
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392472
HARROD SYNDROME	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392472
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392472
MOWAT-WILSON SYNDROME	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392472
DONNAI-BARROW SYNDROME	0.000541419	0.020311956543392472
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.020311956543392472
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392472
HENNEKAM SYNDROME	0.000541419	0.020311956543392472
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392472
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392472
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000541419	0.020311956543392472
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000541419	0.020311956543392472
DISTAL TRISOMY 17Q	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.020311956543392472
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392472
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392472
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392472
TRISOMY 13	0.000541419	0.020311956543392472
GM1 GANGLIOSIDOSIS	0.000541419	0.020311956543392472
TRISOMY X	0.000541419	0.020311956543392472
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392472
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392472
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020311956543392472
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000541419	0.020311956543392472
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392472
WILSON-TURNER SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.020311956543392472
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392472
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.000541419	0.020311956543392472
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392472
GALACTOSIALIDOSIS	0.000541419	0.020311956543392472
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392472
FUCOSIDOSIS	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.020311956543392472
CHIME SYNDROME	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392472
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392472
WOLFRAM SYNDROME	0.000541419	0.020311956543392472
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.020311956543392472
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
SCHAAF-YANG SYNDROME; SHFYNG	0.000541419	0.020311956543392472
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000541419	0.020311956543392472
FILIPPI SYNDROME	0.000541419	0.020311956543392472
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020311956543392472
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.020311956543392472
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.020311956543392472
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000541419	0.020311956543392472
TETRASOMY 9P	0.000541419	0.020311956543392472
TETRASOMY 5P	0.000541419	0.020311956543392472
TETRASOMY 18P	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392472
DUPLICATION/INVERSION 15Q11	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392472
MERCURY POISONING	0.000541419	0.020311956543392472
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020311956543392472
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000541419	0.020311956543392472
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392472
RENPENNING SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.020311956543392472
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392472
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.020311956543392472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392472
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392472
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000541419	0.020311956543392472
PONTINE TEGMENTAL CAP DYSPLASIA	0.000541419	0.020311956543392472
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000541419	0.020311956543392472
LISSENCEPHALY 4	0.000541419	0.020311956543392472
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.020311956543392472
SSR4-CDG	0.000541419	0.020311956543392472
STT3B-CDG	0.000541419	0.020311956543392472
STT3A-CDG	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.020311956543392472
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.020311956543392472
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020311956543392472
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392472
PRADER-WILLI-LIKE SYNDROME	0.000541419	0.020311956543392472
MAN1B1-CDG	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.020311956543392472
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.020311956543392472
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
WITTEVEEN-KOLK SYNDROME	0.000541419	0.020311956543392472
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.020311956543392472
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000541419	0.020311956543392472
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392472
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.020311956543392472
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.020311956543392472
DISTAL MONOSOMY 1Q	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.000541419	0.020311956543392472
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000541419	0.020311956543392472
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392472
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 3; CSS3	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 4; CSS4	0.000541419	0.020311956543392472
19P13.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000541419	0.020311956543392472
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000541419	0.020311956543392472
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.020311956543392472
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
PERRAULT SYNDROME 3	0.000541419	0.020311956543392472
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392472
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392472
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.020311956543392472
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392472
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392472
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MEVALONIC ACIDURIA	0.000541419	0.020311956543392472
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.000541419	0.020311956543392472
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.020311956543392472
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.020311956543392472
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020311956543392472
PITT-HOPKINS SYNDROME	0.000541419	0.020311956543392472
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.020311956543392472
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020311956543392472
TARP SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020311956543392472
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020311956543392472
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392472
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020311956543392472
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.020311956543392472
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000541419	0.020311956543392472
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020311956543392472
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.020311956543392472
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392472
HEART AND BRAIN MALFORMATION SYNDROME	0.000541419	0.020311956543392472
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 5	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
ZTTK SYNDROME; ZTTKS	0.000541419	0.020311956543392472
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000541419	0.020311956543392472
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392472
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.020311956543392472
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392472
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392472
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392472
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.020311956543392472
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020311956543392472
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.000541419	0.020311956543392472
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.020311956543392472
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.020311956543392472
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
TYROSINEMIA TYPE 2	0.000541419	0.020311956543392472
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392472
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392472
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.020311956543392472
LISSENCEPHALY 8; LIS8	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000541419	0.020311956543392472
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000541419	0.020311956543392472
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392472
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000541419	0.020311956543392472
SEVERE CANAVAN DISEASE	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.020311956543392472
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.020311956543392472
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392472
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000541419	0.020311956543392472
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020311956543392472
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.020311956543392472
20P13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392472
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
WIEDEMANN-STEINER SYNDROME	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
AICARDI-GOUTIERES SYNDROME 7	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.020311956543392472
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392472
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000541419	0.020311956543392472
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.020311956543392472
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392472
WEBB-DATTANI SYNDROME; WEDAS	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392472
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.020311956543392472
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.020311956543392472
RUVALCABA SYNDROME	0.000541419	0.020311956543392472
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.020311956543392472
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000541419	0.020311956543392472
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020311956543392472
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
DESANTO-SHINAWI SYNDROME	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000541419	0.020311956543392472
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.020311956543392472
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000541419	0.020311956543392472
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000541419	0.020311956543392472
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020311956543392472
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392472
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392472
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.020311956543392472
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392472
